Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility Study of the Magenta Elevate™ Percutaneous Left Ventricular Assist Device (pLVAD) System in Patients With Cardiogenic Shock

NCT07293923 is registered in ClinicalTrials.gov with Magenta Medical Ltd. as lead sponsor.

NCT NCT07293923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07293923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility Study of the Magenta Elevate™ Percutaneous Left Ventricular Assist Device (pLVAD) System in Patients With Cardiogenic Shock
Lead sponsor
Magenta Medical Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
November 5, 2025
Completion date
February 28, 2028
Enrollment
10 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami), cardiogenic shock, heart failure